3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Non-Small-Cell Lung
59
Squamous Cell Carcinoma of Head and Neck
37
Nasopharyngeal Carcinoma
27
Lung Neoplasms
26
Uterine Cervical Neoplasms
22
Biliary Tract Neoplasms
22
Esophageal Squamous Cell Carcinoma
20
Oropharyngeal Neoplasms
18
Head and Neck Neoplasms
17
Cholangiocarcinoma
16
Neoplasms
15
Neoplasm Metastasis
15
Urinary Bladder Neoplasms
14
Ovarian Neoplasms
13
Carcinoma
13
Esophageal Neoplasms
12
Colorectal Neoplasms
12
Stomach Neoplasms
10
Small Cell Lung Carcinoma
10
Carcinoma, Transitional Cell
8
Mouth Neoplasms
7
Laryngeal Neoplasms
7
Hypopharyngeal Neoplasms
7
Carcinoma, Squamous Cell
7
Recurrence
6
Pancreatic Neoplasms
5
Neoplasms by Site
5
Nasopharyngeal Neoplasms
5
Endometrial Neoplasms
5
Breast Neoplasms
5
Interventions
pembrolizumab
5
fludarabine
2
enfortumab vedotin
2
darolutamide
2
atezolizumab
2
aldesleukin
2
Riluzole
2
Nivolumab
2
Mitomycin
2
Fecal Microbiota Transplantation
2
Cyclophosphamide
2
vedolizumab
1
relatlimab
1
prednylidene
1
olaparib
1
lenvatinib
1
deltacortene
1
cabozantinib
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Tadalafil
1
Surveys and Questionnaires
1
Standard of Care
1
Specimen Handling
1
Rivaroxaban
1
Radiosurgery
1
Radiation Dose Hypofractionation
1
Pregnancy Tests
1
Prednisone
1
Practice Guidelines as Topic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Urogenital Neoplasms
×
Cisplatin
×
Clear all
NCT07566156
2026-06-08
EV-309
Astellas Pharma Inc
Phase 3
Recruiting
390 enrolled